Allovir, Inc. Business Finance Contracts & Agreements

10 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Kalaris Therapeutics, Inc. 2020 Stock Option and Grant Plan, as amended, and form of award agreements thereunder
Stock Agreements
Allovir, Inc.
Biotechnology
2025
Kalaris Therapeutics, Inc. 2020 Stock Option and Grant Plan, as amended, and form of award agreements thereunder
Stock Agreements
Allovir, Inc.
Biotechnology
2025
Underwriting Agreement, dated June 21, 2023, by and among AlloVir, Inc., J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC and BoFA Securities, Inc. as representatives of the...
Underwriting Agreements
Allovir, Inc.
Biotechnology
NY
2023
Securities Purchase Agreement, dated as of July 26, 2022, by and between AlloVir, Inc. and the investors identified therein
Purchase Agreements
Allovir, Inc.
Biotechnology
NY
2022
Redeemable Preferred Stock Redemption Agreement among the Registrant and certain of its stockholders, effective as of September 17, 2018
Stock Agreements
Allovir, Inc.
Biotechnology
DE
2020
2020 Employee Stock Purchase Plan
Stock Agreements
Allovir, Inc.
Biotechnology
MA
2020
2020 Stock Option and Grant Plan, and form of award agreements thereunder
Stock Agreements
Allovir, Inc.
Biotechnology
MA
2020
Specimen Common Stock Certificate
Stock Agreements
Allovir, Inc.
Biotechnology
2020
Form of Underwriting Agreement
Underwriting Agreements
Allovir, Inc.
Biotechnology
NY
2020
Amended and Restated Investors Rights Agreement among the Registrant and certain of its stockholders, effective as of May 8, 2019
Investor Rights Agreements
Allovir, Inc.
Biotechnology
DE
2020